Patents matching “antibody”

US 9845357

Integrin αvβ8 neutralizing antibody

The Regents of the University of California · Granted Dec 19, 2017 · Expires Dec 14, 2037

US 9840558

Human antibody specific for interleukin-1alpha

XBIOTECH INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

US 9765147

Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

Five Prime Therapeutics, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

US 9694071

Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

TG Therapeutics, Inc. · Granted Jul 4, 2017 · Expires Jun 29, 2037

US 9676858

Human bispecific EGFRvIII antibody and CD3 engaging molecules

The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Jun 13, 2017 · Expires Jun 8, 2037

US 9650436

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 16, 2017 · Expires May 11, 2037

US 9644018

Antibody modulators of APLNR

REGENERON PHARMACEUTICALS, INC. · Granted May 9, 2017 · Expires May 4, 2037

US 9636412

Conjugates of an anti-TNF-alpha antibody

Nektar Therapeutics · Granted May 2, 2017 · Expires Apr 27, 2037

US 9592290

Monoclonal antibody therapy for pancreas cancer

PRECISION BIOLOGICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9592238

Anti-ceramide monoclonal antibody 2A2

The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9574012

AGR2 blocking antibody and use thereof

Sanofi (China) Investment Co., Ltd. Shanghai Branch · Granted Feb 21, 2017 · Expires Feb 16, 2037

US 9567393

Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9527903

Engineered antibody constant domain molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9512212

Bispecific antibody fragments for neurological disease proteins and methods of use

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9505826

Modified antibody with improved half-life

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Nov 29, 2016 · Expires Nov 24, 2036

US 9499608

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 22, 2016 · Expires Nov 17, 2036

US 9453078

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

US 9441048

Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

US 9399672

Hepatitis C virus neutralizing antibody

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 26, 2016 · Expires Jul 21, 2036

US 9358306

Photosensitizing antibody-fluorophore conjugates

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

US 9359429

Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof

PROTEIN DESIGN LAB, LTD. · Granted Jun 7, 2016 · Expires Jun 2, 2036

US 9353176

Method of treating osteoarthritis with an antibody to NGF

REGENERON PHARMACEUTICALS, INC. · Granted May 31, 2016 · Expires May 26, 2036

US 9308256

Method of treating rheumatoid arthritis with an anti-IL-6R antibody

REGENERON PHARMACEUTICALS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

US 9290572

Integrin α-Vβ8 neutralizing antibody

The Regents of the University of California · Granted Mar 22, 2016 · Expires Mar 17, 2036